An Open-Label, Single-Group Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
Launched by ZENCHI, INC. · Jul 11, 2025
Trial Information
Current as of August 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether two herbal supplements, called Elix Cycle Balance and Elix Daily Harmony, can help reduce symptoms related to uterine fibroids—non-cancerous growths in the uterus that can cause menstrual pain and discomfort. The study will last 24 weeks and will include about 42 women who will take these supplements daily. Participants will also fill out questionnaires during the study to share how their symptoms and quality of life are changing.
To join the study, women need to be between 20 and 45 years old, have a healthy weight, and have been diagnosed with uterine fibroids. They should experience moderate to severe menstrual pain and related symptoms like cramps, bloating, mood swings, or tiredness, and have had these symptoms consistently for at least six months. Women who use hormonal birth control or other supplements can join if their routines have been stable for at least three months and they agree not to make changes during the study. Participants will be expected to take the supplements daily, complete regular surveys about their symptoms, and maintain their usual lifestyle and exercise habits. It’s important to note that this study is not yet recruiting, and there are several health and lifestyle factors that might affect eligibility, so not everyone will qualify.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Be female.
- • Be aged 20-45.
- • BMI 18.5 - 24.9 kg/m2
- • Self-reported prior diagnosis of uterine fibroids.
- • Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- • Self-reported moderate to severe discomfort during menstruation, related to pelvic cramps, bloating, mood swings, or fatigue.
- • Self-reported menstrual cramps during their cycle, for the past six months minimum.
- • If taking hormonal birth control, has been doing so consistently for at least three months, and experiences a menstrual cycle with a period.
- • If taking other oral over-the-counter supplements or herbal remedies, has been consistently taking these for at least three months prior to starting the study, and is willing to maintain this routine for the study duration.
- • Willing to refrain from introducing any products or any new forms of medication or supplements for the study duration.
- • Willing to refrain from any other dietary supplements or herbal remedies targeting the menstrual cycle during the study period.
- • Willing to refrain from any new vaccines during the 6 month period.
- • Follows a stable, consistent exercise regimen and are willing, for the duration of the study, to not decrease or increase the amount of exercise in their regimen.
- • Agrees to refrain from any lifestyle changes that may affect their menstrual cycle for the duration of the study (for example, getting on or off hormonal birth control, reducing the amount of exercise).
- • If using any other interventions, such as massage, chiropractic medicine, or acupuncture, agrees not to increase or decrease the number of these other interventions during the study period.
- • Resides in the United States.
- Exclusion Criteria:
- • Does not experience a regular menstrual cycle (21-35 days).
- • Does not experience menstrual cramping.
- • Follows an extreme diet intervention such as dry fasts, water fasts, or ketogenic diets.
- • Anyone who has experienced significant weight loss in the past three months prior to study participation.
- • Unwilling to stop the use of any medication or herbal remedies/supplements that can affect the menstrual cycle.
- • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
- • Anyone with known severe allergic reactions.
- • Anyone with any allergies or sensitivities to any of the study product ingredients.
- • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
- • Anyone unwilling to follow the study protocol.
- • Has stopped, started, or changed hormonal birth control in the past three months.
- • Previous users of Elix Cycle Balance.
- • Anyone who is currently a smoker or has been a smoker in the past 3 months.
- • Anyone who has been diagnosed with the following conditions: PCOS, Endometriosis, PMDD, Adenomyosis, Hashimoto's thyroiditis, Grave's disease (and any other thyroid disorders), hyperprolactinemia, Cushing's disease, congenital adrenal hyperplasia, anorexia, bulimia, orthorexia, binge eating, any other eating disorder.
- • History of endocrine disorders such as thyroid disorder, Type 1 or 2 diabetes, or other.
- • History of hypertension, hyperlipidemia, or previous venous embolism.
- • Overweight/obesity (BMI \> 25 kg/m2).
- • Women with other causes of chronic pelvic pain, including infectious disease, gastrointestinal, psychological disorders, fibromyalgia, and chronic fatigue syndrome.
- • Hysterectomy, myomectomy, or bilateral salpingo-oophorectomy or other gynecological medical or surgical treatment in the last 6 months.
- • History of an abnormal pap smear.
- • History of neoplasia of gynecological origin and/or existence of uterine malformations.
- • Chronic urinary tract infections or diagnosed functional gastrointestinal conditions like IBS, IBD, Crohn's disease, or ulcerative colitis.
- • Currently partaking in another research study or will be partaking in any other research study for the next 24 weeks, or at any point during this study's duration.
- • Consume more than 5 alcoholic drinks per week
- • Had a vaccine in the last 3 months
About Zenchi, Inc.
Zenchi, Inc. is a clinical trial sponsor dedicated to advancing innovative therapeutic solutions through rigorous research and development in the healthcare sector. Committed to improving patient outcomes, Zenchi specializes in the design, management, and execution of clinical trials across various therapeutic areas. With a focus on collaboration and ethical practices, the company leverages cutting-edge technology and a highly skilled team to ensure the highest standards of scientific integrity and compliance. Zenchi, Inc. strives to bridge the gap between groundbreaking research and effective treatment options, ultimately enhancing the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Las Vegas, Nevada, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported